Blend identity and evidence limits
GLOW-70 (GHK-Cu + TB-500 + BPC-157)
Why GLOW-70 is a commercial blend label rather than a verified improvement over another GLOW product.
Source and review status
Identity unresolved
Identity search checked on: 6 September 2026
Qualified clinical review: Pending. This page has not been clinically reviewed.
About this source check
AI-assisted editorial source checking covers the cited material and its stated limits. It is not a systematic review, verification of a supplied product, or clinical sign-off.
Editorial role: InfoAddict. Last material change: 6 September 2026. Next source review: 6 December 2026.
Identity and comparison limits
GLOW-70 is listed in this catalogue as a GHK-Cu, TB-500 and BPC-157 combination. The label does not establish a standardised formula. A larger number than GLOW-50 is not evidence of greater effectiveness, better absorption or improved tolerability.
A specific TB-500 problem
FDA identifies TB-500 as a thymosin beta-4 fragment and reports no identified human exposure data for drug products containing that fragment in its assessment. Full-length thymosin beta-4 research therefore cannot automatically be used to validate a TB-500-labelled mixture.
Sources: U.S. Food and Drug Administration
Unresolved product questions
The exact forms and ratios, manufacturing controls and clinical outcomes remain unverified. Comparisons between GLOW-50 and GLOW-70 would require matched formulations and direct evidence. No such primary comparison was located in the targeted source check. The reference records that gap without declaring the products equivalent.
Published sources
- Certain Bulk Drug Substances for Use in Compounding that May Present Significant Safety Risks
U.S. Food and Drug Administration. Current FDA reference; accessed 6 September 2026.
Supports: Named substance and route-specific safety findings. Ingredient assessments do not validate a finished blend.
Change history
| Date | Change | Clinical-review status |
|---|---|---|
| 6 September 2026 | Identity and evidence limits documented | Pending |
Keep a private record
UpgradeYourself lets you keep private records of routines and observations you choose to discuss with a qualified health professional. This reference does not recommend starting, stopping or changing an item.